Loading…
Loading grant details…
| Funder | Swedish Research Council |
|---|---|
| Recipient Organization | Uppsala University |
| Country | Sweden |
| Start Date | Jan 01, 2021 |
| End Date | Dec 31, 2024 |
| Duration | 1,460 days |
| Number of Grantees | 6 |
| Roles | Co-Investigator; Principal Investigator |
| Data Source | Swedish Research Council |
| Grant ID | 2020-06175_VR |
Analysis of multi-omics data, e.g.
DNA, RNA and protein data, provide the basis of large-scale data-driven biology and medicine, but is based on technologies that are difficult to integrate in a single analysis.
In this project we will develop a technology solution that enables simultaneous integrated multi-omics large-scale analyses using next generation DNA sequencing (NGS) as a single read-out technology.
The project is a collaboration between the National Genomics Infrastructure (NGI) and the Clinical Biomarkers Facility (CBF) at SciLifeLab and the Swedish biotechnology company Olink Proteomics AB and includes three parts: A.
Establishing Olink’s technology for multiplex protein analysis with an NGS readout as a service in NGI/CBF and make it available to researchers, health-care and the business sector. B.
Develop methods for simultaneous large-scale analysis of protein, DNA, and RNA targets using a single read-out technology. This project combines NGI’s sequencing expertise and Olinks experience of multiplex protein analysis using PEA. C.
Design targeted multi-omics clinical assays combining the diagnosis of DNA mutations, RNA expression levels and protein levels in a single NGS read-out.
The project will result in technologies that revolutionize our ability to generate multi-omics data from biological samples, and thereby contribute to a more complete understanding of complex biological processes and our ability to deliver on the promise of personalized health-care.
Uppsala University
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant